Viral triggers for autoimmunity: Is the 'glass of molecular mimicry' half full or half empty?

Journal of Autoimmunity

Volumn 34, Issue 1, 2010, Pages 38-44

  Christen, Urs ^a   Hintermann, Edith ^a   Holdener, Martin ^a   von Herrath, Matthias G ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Cytochrome P450; Inflammation; Liver disease; Tolerance; Virus infection

Indexed keywords

ANTIGEN; CYTOCHROME P450 2D6;

ANTIBODY TITER; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HOST; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; AUTOANTIGENS; AUTOIMMUNITY; CLONAL DELETION; CYTOCHROME P-450 CYP2D6; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HEPATITIS, AUTOIMMUNE; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR MIMICRY; STRUCTURAL HOMOLOGY, PROTEIN; VIRUS DISEASES;

EID: 75149177988     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.08.001     Document Type: Review

References (49)

1. Christen U., and Herrath M.G. Initiation of autoimmunity. Curr Opin Immunol 16 (2004) 759-767
2. Christen U., and von Herrath M.G. Infections and autoimmunity - good or bad?. J Immunol 174 (2005) 7481-7486
3. Ercolini A.M., and Miller S.D. The role of infections in autoimmune disease. Clin Exp Immunol 155 (2009) 1-15
4. Srinivasappa J., Saegusa J., Prabhakar B.S., Gentry M.K., Buchmeier M.J., Wiktor T.J., et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 57 (1986) 397-401
5. Christen U., and von Herrath M.G. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 40 (2004) 1113-1120
6. Ang C.W., Jacobs B.C., and Laman J.D. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol 25 (2004) 61-66
7. Kirvan C.A., Swedo S.E., Heuser J.S., and Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9 (2003) 914-920
8. Gershwin M.E., and Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47 (2008) 737-745
9. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38 (2003) 1250-1257
10. Amano K., Leung P.S., Rieger R., Quan C., Wang X., Marik J., et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174 (2005) 5874-5883
11. Wakabayashi K., Lian Z.X., Leung P.S., Moritoki Y., Tsuneyama K., Kurth M.J., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48 (2008) 531-540
12. Oldstone M.B.A., Nerenberg M., Southern P., Price J., and Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65 (1991) 319-331
13. van der Most R.G., Murali-Krishna K., Whitton J.L., Oseroff C., Alexander J., Southwood S., et al. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240 (1998) 158-167
14. von Herrath M.G., Dockter J., Nerenberg M., Gairin J.E., and Oldstone M.B. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med 180 (1994) 1901-1910
15. von Herrath M.G., Dockter J., and Oldstone M.B.A. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1 (1994) 231-242
16. Tian S., Maile R., Collins E.J., and Frelinger J.A. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol 179 (2007) 2952-2960
17. Gronski M.A., Boulter J.M., Moskophidis D., Nguyen L.T., Holmberg K., Elford A.R., et al. TCR affinity and negative regulation limit autoimmunity. Nat Med 10 (2004) 1234-1239
18. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., and Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406 (2000) 739-742
19. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., et al. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 115 (2005) 1879-1887
20. Han B., Serra P., Amrani A., Yamanouchi J., Maree A.F., Edelstein-Keshet L., et al. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 11 (2005) 645-652
21. Slifka M.K., and Whitton J.L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2 (2001) 711-717
22. von Herrath M., and Holz A. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. J Autoimmun 10 (1997) 231-238
23. Christen U., McGavern D.B., Luster A.D., von Herrath M.G., and Oldstone M.B. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171 (2003) 6838-6845
24. Seewaldt S., Thomas H., Ejrnaes M., Christen U., Wolfe T., Rodrigo E., et al. Virus-induced autoimune diabetes: most b-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) CTL. Diabetes 49 (2000) 1801-1809
25. Bresson D., Togher L., Rodrigo E., Chen Y., Bluestone J.A., Herold K.C., et al. Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116 (2006) 1371-1381
26. Christen U., Benke D., Wolfe T., Rodrigo E., Rhode A., Hughes A.C., et al. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J Clin Invest 113 (2004) 74-84
27. Christen U., Wolfe T., Mohrle U., Hughes A.C., Rodrigo E., Green E.A., et al. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166 (2001) 7023-7032
28. Coon B., An L.-L., Whitton J.L., and von Herrath M.G. DNA immunization to prevent autoimmune diabetes. J Clin Invest 104 (1999) 189-194
29. Homann D., Jahreis A., Wolfe T., Hughes A., Coon B., van Stipdonk M.J., et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16 (2002) 403-415
30. Christen U., Edelmann K.H., McGavern D.B., Wolfe T., Coon B., Teague M.K., et al. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 114 (2004) 1290-1298
31. Rhode A., Pauza M.E., Barral A.M., Rodrigo E., Oldstone M.B., von Herrath M.G., et al. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J Immunol 175 (2005) 3516-3524
32. Sevilla N., Homann D., von Herrath M., Rodriguez F., Harkins S., Whitton J.L., et al. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J Virol 74 (2000) 3284-3292
33. Brehm M.A., Pinto A.K., Daniels K.A., Schneck J.P., Welsh R.M., and Selin L.K. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3 (2002) 627-634
34. Selin L.K., Lin M.Y., Kraemer K.A., Pardoll D.M., Schneck J.P., Varga S.M., et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11 (1999) 733-742
35. Vezys V., Yates A., Casey K.A., Lanier G., Ahmed R., Antia R., et al. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457 (2009) 196-199
36. Holdener M., Hintermann E., Bayer M., Rhode A., Rodrigo E., Hintereder G., et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 205 (2008) 1409-1422
37. Manns M.P., Johnson E.F., Griffin K.J., Tan E.M., and Sullivan K.F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 83 (1989) 1066-1072
38. Zanger U.M., Hauri H.P., Loeper J., Homberg J.C., and Meyer U.A. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A 85 (1988) 8256-8260
39. Corchero J., Granvil C.P., Akiyama T.E., Hayhurst G.P., Pimprale S., Feigenbaum L., et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 60 (2001) 1260-1267
40. Holdener M, Bogdanos DP, Christen S, Bayer M, Pfeilschifter J, Hintermann E, et al. The CYP2D6 model for autoimmune hepatitis: Characterization of the CD4 and CD8 T cells response, unpublished observation.
41. Nelson S.D., and Pearson P.G. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 30 (1990) 169-195
42. Park B.K., and Kitteringham N.R. Drug-protein conjugation and its immunological consequences. Drug Metab Rev 22 (1990) 87-144
43. Mehal W.Z., Juedes A.E., and Crispe I.N. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 163 (1999) 3202-3210
44. Reinhardt R.L., Khoruts A., Merica R., Zell T., and Jenkins M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410 (2001) 101-105
45. Bowen D.G., Zen M., Holz L., Davis T., McCaughan G.W., and Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114 (2004) 701-712
46. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6 (2000) 1348-1354
47. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51-62
48. Luth S., Huber S., Schramm C., Buch T., Zander S., Stadelmann C., et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118 (2008) 3403-3410
49. Chen C.H., Kuo L.M., Chang Y., Wu W., Goldbach C., Ross M.A., et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44 (2006) 1171-1181